Research

Dry eye statistics

How many people have dry eye disease, who is most affected, and why published estimates range from a few percent to half the population. Every figure is scoped to the study it came from.

By the Scleral Lens Team · Updated October 2, 2026 · 11 published sources cited

The short answer

Dry eye disease is common, but how common depends on how it's defined. An international expert review found prevalence ranging from 5% to 50% across studies. In the US, a national survey estimated that 6.8% of adults, about 16.4 million people, have been diagnosed with it. It becomes more common with age and is more common in women. Only a small share of people with dry eye need scleral lenses, which are generally used after other treatments have been tried.

Key points

  • Worldwide estimates range from 5% to 50% depending on definition.
  • 6.8% of US adults reported a dry eye diagnosis in a 2013 national survey.
  • Prevalence rises steeply with age: 2.7% at 18–34 vs 18.6% at 75+ in that survey.
  • Women are affected more often than men.
  • Scleral lenses are usually a later-line option for severe ocular surface disease.

This page is about dry eye in general. For the severe forms that scleral lenses are used for, see scleral lenses for severe dry eye and the conditions list.

Why the numbers vary so much

Dry eye disease isn’t one thing measured one way. The international Tear Film and Ocular Surface Society’s 2017 workshop (TFOS DEWS II) defined it as a multifactorial disease involving loss of tear film balance, with symptoms that can include discomfort or visual disturbance, and recognized that signs and symptoms don’t always go together.[2]

So studies count different things:

  • A doctor’s diagnosis, found in survey answers or insurance codes.
  • Symptoms, reported on a questionnaire.
  • Signs, found in an eye exam, such as tear film instability or surface staining.

The TFOS DEWS II epidemiology review found that prevalence ranged from 5% to 50% across published studies. Signs were more common, and more variable, than symptoms.[1] Keep this in mind when comparing any two figures below: they are often measuring different things.

Worldwide

A 2021 analysis combined studies published between 1997 and 2021 using a Bayesian method. Its estimates show how much the definition matters:[3]

Definition used Estimated global prevalence[3]
Symptoms 9.12%
All studies combined 11.59%
TFOS DEWS II diagnostic criteria 29.5%
Signs 35.2%

Prevalence also varied by region. For symptomatic dry eye, the estimate was lowest in North America (4.6%) and highest in Africa (47.9%). The author noted that data were sparse for young people and for every region except Eastern Asia.[3]

United States

Three large US studies used different populations and methods:

Study Who was counted How Overall estimate
National Health and Wellness Survey, 2013 75,000 adults, weighted to the US adult population Self-reported diagnosis 6.8%, about 16.4 million adults[4]
Military Health System, 2003–2015 9.7 million beneficiaries aged 2 to 80+ Diagnosis codes and dry eye prescriptions 5.28%[5]
Women’s Health Study 39,876 women, adjusted to US women aged 50+ Diagnosis or severe symptoms 7.8%, about 3.23 million women[6]
Physicians’ Health Studies I and II 18,596 and 6,848 men aged 50+, adjusted to US men Diagnosis or severe symptoms 4.34%, about 1.68 million men[7]

These don’t add up to a single US total. They cover different ages and time periods and use different definitions.

Age

Every study agrees: dry eye becomes more common with age.

  • In the 2013 national survey, diagnosed dry eye rose from 2.7% of adults aged 18 to 34 to 18.6% of those aged 75 and older.[4]
  • In the military health data, prevalence rose from 0.20% in children and teens aged 2 to 17 to 11.66% in people aged 50 and older.[5]
  • In the Women’s Health Study, it rose from 5.7% among women under 50 to 9.8% among those 75 and older.[6]
  • In the Physicians’ Health Studies, it rose from 3.90% at ages 50 to 54 to 7.67% at 80 and older.[7]

The international review found that signs increased more per decade of age than symptoms did.[1]

Sex

Women are affected more often than men in most studies.

  • US national survey: 8.8% of women (about 11.1 million) vs 4.5% of men (about 5.3 million).[4]
  • Military health data: 7.78% of women vs 2.96% of men.[5]
  • International review: women have a higher prevalence than men, but the difference becomes significant only with age.[1]

Other risk factors

The international review classed Asian ethnicity as a mostly consistent risk factor.[1] In the study of US men, high blood pressure, benign prostatic hyperplasia, and the use of antidepressants, blood pressure medicines, and prostate medicines were associated with higher risk.[7] The review also found the burden of dry eye on vision, quality of life, and work productivity to be considerable.[1]

Where scleral lenses come in

Scleral lenses aren’t a routine dry eye treatment. They’re used for severe ocular surface disease, usually after other treatments haven’t worked.

  • They make up a minority of scleral fits. In a 2020 survey of 777 experienced fitters, a median of 10% of scleral lenses were fitted for ocular surface disease.[8] In an international survey describing 259 individual patients, 9% were fitted for ocular surface disease.[9]
  • Fitters usually try other treatments first. In a survey of 778 scleral lens practitioners, lubricating drops were the most common first choice for ocular surface disease (63% ranked them first), followed by gland expression, prescription anti-inflammatory drops, steroids, and punctal plugs. Scleral lenses were generally considered after those but before surgery.[10]
  • For those who need them, they can help. At one US tertiary center, people fitted with scleral lenses for ocular surface disease had tried an average of 3.2 other treatments first. Of the 115 who completed fitting, all but 2 met their treatment goals, such as better comfort, surface protection, or healing.[11]

There’s no reliable figure for how many people with dry eye have disease severe enough to need a scleral lens. If yours is severe and hasn’t responded to other treatment, ask your eye doctor whether a scleral lens evaluation makes sense.

Common questions

How many Americans have dry eye?

A 2013 national survey of 75,000 adults projected that 6.8% of US adults, about 16.4 million people, had been diagnosed with dry eye disease. Counting people with symptoms but no diagnosis would give a higher number.

Why do dry eye statistics vary so much?

Studies define dry eye differently. Some count people with a doctor's diagnosis, some count symptoms on a questionnaire, and some count signs found in an eye exam. Signs are found more often, and vary more, than symptoms. An international expert review found prevalence ranging from 5% to 50% across studies.

Is dry eye more common in women?

Yes, in most studies. In the 2013 US survey, 8.8% of women had a diagnosis compared with 4.5% of men. The international expert review found the difference between women and men becomes significant mainly with age.

Does dry eye get worse with age?

It becomes more common with age. In the US survey, diagnosed dry eye rose from 2.7% of adults aged 18 to 34 to 18.6% of those aged 75 and older.

How many people with dry eye need scleral lenses?

There isn't a reliable figure. Scleral lenses are generally reserved for severe ocular surface disease that hasn't responded to other treatments. In a 2020 survey of experienced fitters, a median of 10% of their scleral lenses were fitted for ocular surface disease.

Keep reading

Scleral lens wearer statistics

No registry counts how many people wear scleral lenses, so the best data come from surveys of fitters and from large practices. They agree on the main point: most scleral lenses are prescribed for irregular corneas such as keratoconus, a smaller share for ocular surface disease, and very few for ordinary prescriptions. Scleral lenses are a growing part of rigid lens fitting worldwide, and more practitioners are fitting them than a decade ago.

Scleral lens outcomes: what the research shows

Studies consistently find that scleral lenses improve vision for people with irregular corneas, often by a large margin, and improve how people rate their daily visual functioning. But a meaningful share stop wearing them: between about a fifth and a third in the studies below, which followed people for six months to about three years, most often because inserting and removing the lenses is hard. Most of the evidence comes from single clinics and retrospective chart reviews, so the figures are a guide, not a promise.

What are scleral lenses?

Scleral lenses are large, rigid gas-permeable contact lenses that rest on the white of the eye and arch over the cornea without touching it. You fill each lens with sterile saline before putting it in, so a layer of fluid sits over the cornea all day. Most are prescribed for corneas that are irregular, such as in keratoconus, and some for severe dry eye and other surface disease. They often give clearer vision when glasses and other lenses can't, but they take practice to handle and need daily care.

Sources

  1. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334-365. doi:10.1016/j.jtos.2017.05.003 pubmed.ncbi.nlm.nih.gov
  2. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276-283. doi:10.1016/j.jtos.2017.05.008 pubmed.ncbi.nlm.nih.gov
  3. Papas EB. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-1266. doi:10.1111/opo.12888 pubmed.ncbi.nlm.nih.gov
  4. Farrand KF, Fridman M, Stillman IÖ, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90-98. doi:10.1016/j.ajo.2017.06.033 pubmed.ncbi.nlm.nih.gov
  5. Dana R, Bradley JL, Guerin A, et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States health care system. Am J Ophthalmol. 2019;202:47-54. doi:10.1016/j.ajo.2019.01.026 pubmed.ncbi.nlm.nih.gov
  6. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318-326. doi:10.1016/s0002-9394(03)00218-6 pubmed.ncbi.nlm.nih.gov
  7. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol. 2009;127(6):763-768. doi:10.1001/archophthalmol.2009.103 pubmed.ncbi.nlm.nih.gov
  8. Nau CB, Harthan JS, Shorter ES, et al. Trends in scleral lens fitting practices: 2020 SCOPE survey. Eye Contact Lens. 2023;49(2):51-55. doi:10.1097/ICL.0000000000000960 pubmed.ncbi.nlm.nih.gov
  9. Schornack MM, Fogt J, Nau A, et al. Scleral lens prescription and management practices: emerging consensus. Cont Lens Anterior Eye. 2023;46(1):101501. doi:10.1016/j.clae.2021.101501 pubmed.ncbi.nlm.nih.gov
  10. Shorter E, Fogt J, Nau C, et al. Prescription habits of scleral lenses for the management of corneal irregularity and ocular surface disease among scleral lens practitioners. Eye Contact Lens. 2023;49(2):46-50. doi:10.1097/ICL.0000000000000963 pubmed.ncbi.nlm.nih.gov
  11. Schornack MM, Pyle J, Patel SV. Scleral lenses in the management of ocular surface disease. Ophthalmology. 2014;121(7):1398-1405. doi:10.1016/j.ophtha.2014.01.028 pubmed.ncbi.nlm.nih.gov

Last updated October 2, 2026. Found an error or a newer study? Let us know and we'll correct the page.